Sensibility and Specificity of the VitaPCR™ SARS-CoV-2 Assay for the Rapid Diagnosis of COVID-19 in Older Adults in the Emergency Department.
SARS-CoV-2
VitaPCR
rapid diagnostic test
sensitivity
specificity
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
09 01 2023
09 01 2023
Historique:
received:
23
11
2022
revised:
28
12
2022
accepted:
06
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
(1) Background: During the COVID-19 pandemic, rapid and reliable diagnostic tools are needed for detecting SARS-CoV-2 infection in urgent cases at admission to the hospital. We aimed to assess the performances of the rapid molecular VitaPCR™ test (Menarini Diagnostics) in a sample of older adults admitted to the Emergency Department of two Italian hospitals (2) Methods: The comparison between the rapid VitaPCR™ and the RT-PCR was performed in 1695 samples. Two naso-pharyngeal swab samplings from each individual were obtained and processed using the VitaPCR™ and the RT-PCR for the detection of SARS-CoV-2 (3) Results: VitaPCR™ exhibited good precision (<3% CV) and an almost perfect overall agreement (Cohen’s K = 0.90) with the RT-PCR. The limit of detection of the VitaPCR™ was 4.1 copies/µL. Compared to the RT-PCR, the sensitivity, the specificity, and the positive and negative predictive values of VitaPCR™ were 83.4%, 99.9%, 99.2% and 98.3%, respectively (4) Conclusions: The VitaPCR™ showed similar sensitivity and specificity to other molecular-based rapid tests. This study suggests that the VitaPCR™ can allow the rapid management of patients within the Emergency Department. Nevertheless, it is advisable to obtain a negative result by a RT-PCR assay before admitting a patient to a regular ward.
Identifiants
pubmed: 36680229
pii: v15010189
doi: 10.3390/v15010189
pmc: PMC9866422
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2013 Sep 09;8(9):e73845
pubmed: 24040090
J Clin Virol. 2020 Jul;128:104426
pubmed: 32417674
JAMA Intern Med. 2020 Nov 01;180(11):1447-1452
pubmed: 32780793
Elife. 2021 Apr 20;10:
pubmed: 33876726
J Clin Med. 2020 May 18;9(5):
pubmed: 32443459
N Engl J Med. 2022 Jan 20;386(3):264-272
pubmed: 34995029
Saf Health Work. 2020 Jun;11(2):241-243
pubmed: 32292622
J Infect Dis. 2020 Aug 17;222(6):899-902
pubmed: 32594170
Reg Anesth Pain Med. 2020 Aug;45(8):579-585
pubmed: 32475827
Health Aff (Millwood). 2020 Nov;39(11):2010-2017
pubmed: 32970495
J Clin Virol. 2020 Dec;133:104682
pubmed: 33152666
Genes (Basel). 2020 Jun 18;11(6):
pubmed: 32570810
J Med Virol. 2021 Jul;93(7):4523-4531
pubmed: 33913533
Clin Chem. 2020 Jun 1;66(6):794-801
pubmed: 32246822
J Clin Virol. 2020 Jul;128:104410
pubmed: 32403009
J Hosp Infect. 2020 Jun;105(2):113-115
pubmed: 32294511
J Med Virol. 2021 Jul;93(7):4351-4357
pubmed: 33738829
Lancet. 2020 May 2;395(10234):1418-1420
pubmed: 32305073
Chest. 2020 Oct;158(4):1364-1375
pubmed: 32533957
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32461285
J Am Coll Emerg Physicians Open. 2021 Dec 29;2(6):e12592
pubmed: 35005704
Lancet Microbe. 2020 Nov;1(7):e300-e307
pubmed: 32964211
Proc Natl Acad Sci U S A. 2021 May 25;118(21):
pubmed: 33972412